UBC Medical Indonesia Tbk.
LABS.JK
Get informed when a big investor buys or sells
+ FollowMarket Cap$620.15B
Close$
Share Statistics
| Market cap | $620.15 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.29 |
| Beta | 0.49 |
| Outstanding Shares | 3,950,000,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 58.81 |
|---|---|
| PEG | -222.34 |
| Price to Sales | 3.02 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About UBC Medical Indonesia Tbk.
54 employees
CEO: Franciscus Xaverius Yoshua Raintjung UBC Medical Indonesia Tbk (LABS.JK) serves as a key supplier of medical devices throughout Indonesia. The company's operations are structured into two primary divisions: Medical Disposables and Consumables, and Diagnostics and Equipment....